Global OTC Drugs and Devices Market

The global OTC drugs, medical devices and diagnostics market is expected to increase by USD 154 billion, at a compound annual growth rate (CAGR) of 6.9% from 2022 to 2028, according to the latest edition of the Global OTC Drugs and Devices Market Report.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global OTC drugs, medical devices and diagnostics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the OTC drugs, medical devices and diagnostics industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, disease, and region. The global market for OTC drugs, medical devices and diagnostics can be segmented by product: OTC drugs, OTC medical devices. According to the research, the OTC drugs segment had the largest share in the global OTC drugs, medical devices and diagnostics market. OTC drugs, medical devices and diagnostics market is further segmented by disease: cardiovascular diseases (CVDs), diabetes, ENT disorders, gastrointestinal disorders, obesity, orthopedic disorders, respiratory disorders, skin diseases, sleep disorders, others. In 2021, the diabetes segment made up the largest share of revenue generated by the OTC drugs, medical devices and diagnostics market. Based on region, the OTC drugs, medical devices and diagnostics market is segmented into: Asia Pacific, Europe, USA, Rest of the World (RoW). Among these, USA was accounted for the highest revenue generator in 2021.

By product:
– OTC drugs
– OTC medical devices

By disease:
– cardiovascular diseases (CVDs)
– diabetes
– ENT disorders
– gastrointestinal disorders
– obesity
– orthopedic disorders
– respiratory disorders
– skin diseases
– sleep disorders
– others

By region:
– Asia Pacific
– Europe
– USA
– Rest of the World (RoW)

The OTC medical devices and diagnostics market is further segmented into diagnostic devices and kits, self-care devices and wearables. Gen Consulting Company research indicates that the self-care devices and wearables segment occupied the largest share of this market in 2021 and is expected to draw the highest demand in coming years. Furthermore, the OTC drugs and nutritional products/supplements market has been categorized into pharmaceutical OTC drugs, vitamin and mineral supplements. Globally, the pharmaceutical OTC drugs segment made up the largest share of the OTC drugs, medical devices and diagnostics market.

The report also provides analysis of the key companies of the industry and their detailed company profiles including 3M Company, Abbott Laboratories, AbbVie Inc., AKRON Inc., Amgen Inc., Asahi Kasei Corporation, Aspen Pharmacare Holdings Limited, AstraZeneca plc, Baxter International Inc., Bayer AG, Celgene Corporation, Eli Lilly and Company, Johnson & Johnson, Shanghai Pharmaceuticals Holding Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global OTC drugs, medical devices and diagnostics market.
– To classify and forecast the global OTC drugs, medical devices and diagnostics market based on product, disease, region.
– To identify drivers and challenges for the global OTC drugs, medical devices and diagnostics market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global OTC drugs, medical devices and diagnostics market.
– To identify and analyze the profile of leading players operating in the global OTC drugs, medical devices and diagnostics market.

Why Choose This Report
– Gain a reliable outlook of the global OTC drugs, medical devices and diagnostics market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.

Global OTC Drugs and Devices Market

Interested in this report? Get your FREE sample now!
Global OTC Drugs and Devices Market - Report Scope
REPORT ATTRIBUTE

DETAILS

Base Year

2021

Forecast Year

2022-2028

CAGR (2022-2028)

6.9%

Pages

90

Key Players

3M Company, Abbott Laboratories, AbbVie Inc., AKRON Inc., Amgen Inc., Asahi Kasei Corporation, Aspen Pharmacare Holdings Limited, AstraZeneca plc, Baxter International Inc., Bayer AG, Celgene Corporation, Eli Lilly and Company, Johnson & Johnson, Shanghai Pharmaceuticals Holding Co. Ltd., Taisho Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd.

Related Reports
Global Scar Management Market 2023

The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…

READ MORE

$2,600.00

Want to customize this report?
The present report possesses the flexibility to be tailored to your specific needs. Our team of analysts and industry experts will collaborate directly with you to gain a comprehensive understanding of your requirements.
Scroll to Top

Download Free Sample - Global OTC Drugs and Devices Market

Please fill out our form and we will get back to you.